Dear Research Community, 

 

For nearly 30 years, Bio X Cell has stood beside scientists working at the frontiers of discovery. From cancer to immunology, neuroscience to infectious disease, our mission has been clear: to deliver functional antibodies of uncompromising quality for both classic in vivo models and advanced in vitro systems such as organoids and organ-on-chip platforms, ensuring consistency and reproducibility across the research workflow. 

Today, I am honored to share the next chapter of our journey. Bio X Cell has unveiled a refreshed brand identity that reflects both our history and our future. This evolution is more than a new look. It represents our deepened commitment to advancing science, expanding capabilities, and supporting researchers worldwide. 

Our rebrand signals growth in ways that matter most to you: 

  • Expanded antibody solutions: through continued catalog expansion we are able to offer advanced antibody formats such as biosimilar and bispecific antibodies.
  • Enhanced custom services: we continue to accelerate translational workflows by providing diverse custom services tailored to specialized research projects. 
  • Scalable manufacturing services: The firm operates the world’s largest RUO antibody manufacturing facility, enabling scalable and reliable production from mg to multi-gram scale. 
  • Global operations and distribution: Bio X Cell has established global distribution networks, including direct shipments in the US and Germany, plus facilities in the EU and China, to ensure rapid delivery to researchers.+

 

  • What has not changed is our commitment to your work: supplying you with ultra-pure, low-endotoxin functional antibodies, supported by 100% PhD-level expertise, and guaranteed stability you can trust in your most sensitive studies. 

On behalf of the Bio X Cell team, thank you for your continued trust. This rebrand reflects not only where we have been, but also where we are going, together with you. 

 

With renewed commitment to your science, 

Christopher Conway 

CEO, Bio X Cell